313 serum samples from 155 individuals with previous SARS-CoV-2 infection (with or without SARS-CoV-2 vaccination) were analyzed by two commercially available assays according to the instructions of the manufacturer (anti-SARS-CoV-2-QuantiVac-ELISA (IgG), Euroimmun, Lübeck, Germany and Elecsys Anti-SARS-CoV-2 S, Roche, Mannheim, Germany). For individuals who have been measured several times, the sera were obtained from independent plasma donations performed at different dates. Samples were collected after written informed consent was obtained from convalescent plasma donors (22 (link)) and vaccinated individuals. The studies were approved by the Ethical Committee of University of Ulm and Ethical Committee II, Heidelberg University (392/20, 488/20, 56/21 and 41/22).
Free full text: Click here